ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ERGO Ergomed Plc

1,346.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,346.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ergomed plc Directors' Dealing (6200D)

01/02/2018 9:39am

UK Regulatory


Ergomed (LSE:ERGO)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ergomed Charts.

TIDMERGO

RNS Number : 6200D

Ergomed plc

01 February 2018

Ergomed Plc

("Ergomed" or the "Company")

Directors' Dealing

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 1 February 2018, Mr Peter George, Chairman of the Company, bought 500,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share from Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company. Separately, in response to excess demand from the placing announced by the Company this morning, Dr Miroslav Reljanovic sold an additional 2,000,000 Shares at a price of 190p.

Following these transactions, Mr Peter George holds 776,250 shares (representing 1.8 per cent. of the Company's issued share capital and 1.7 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning) and Dr Miroslav Reljanovic's holding has reduced to 15,132,237 shares (representing 35.5 per cent. of the Company's issued share capital and 33.8 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning).

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
----  ----------------------------------------------------------------------------- 
 a)    Name                               1) Peter George 
                                           2) Dr Miroslav Reljanovic 
----  ----------------------------  ----------------------------------------------- 
 2     Reason for the notification 
----  ----------------------------------------------------------------------------- 
 a)    Position/status                    1) Chairman 
                                           2) Founder and Executive Vice-Chairman 
----  ----------------------------  ----------------------------------------------- 
 b)    Initial notification          Initial Notification 
        /Amendment 
----  ----------------------------  ----------------------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ----------------------------------------------------------------------------- 
 a)    Name                          Ergomed Plc 
----  ----------------------------  ----------------------------------------------- 
 b)    Legal Entity                  213800BVS8I9VMC1AP84 
        Identifier 
----  ----------------------------  ----------------------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ----------------------------------------------------------------------------- 
 a)    Description                   Ordinary shares of 1 pence each 
        of the financial 
        instrument, 
        type of instrument            GB00BN7ZCY67 
 
        Identification 
        code 
----  ----------------------------  ----------------------------------------------- 
 b)    Nature of                          1) Purchase of shares 
        the transaction                    2) Sale of shares 
----  ----------------------------  ----------------------------------------------- 
 c)    Currency                      GBP 
----  ----------------------------  ----------------------------------------------- 
 d)    Price(s) and                        Price(s)                Volume(s) 
        volume(s) 
----  ----------------------------  ----------------------  ----------------------- 
                                             190p                   500,000 
 ---------------------------------  ----------------------  ----------------------- 
                                             190p                  2,500,000 
 ---------------------------------  ----------------------  ----------------------- 
 e)    Aggregated 
        information                         1) 500,000 
        - Aggregated                        2) 2,500,000 
        volume 
        - Price                             1) 190p 
        - Aggregated                        2) 190p 
        total 
                                            1) GBP950,000.00 
                                            2) GBP4,750,000.00 
----  ----------------------------  ----------------------------------------------- 
 f)    Date of the                   1 February 2018 
        transaction 
----  ----------------------------  ----------------------------------------------- 
 g)    Place of the                  London Stock Exchange, AIM 
        transaction 
----  ----------------------------  ----------------------------------------------- 
 

Enquiries:

 
 Ergomed plc                          Tel: +44 (0) 
                                       1483 503205 
 Stephen Stamp (Chief Executive 
  Officer) 
 
 Numis Securities Limited             Tel: +44 (0) 
                                      20 7260 1000 
 Michael Meade / Freddie Barnfield 
  (Nominated Adviser) 
 James Black (Joint Broker) 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANAFEDSPEEF

(END) Dow Jones Newswires

February 01, 2018 04:39 ET (09:39 GMT)

1 Year Ergomed Chart

1 Year Ergomed Chart

1 Month Ergomed Chart

1 Month Ergomed Chart

Your Recent History

Delayed Upgrade Clock